Search Results 2261-2270 of 17345 for Selective mutism

  1. A Study of a New Approach for Assessing Immune Function - Mayo Clinic

    When combined with other studies, it will lead to a better understanding of the immune response to tumors, allergic and infectious agents, and to self. This, in ...

  2. Early Feasibility Study To Evaluate The Safety And Recommended Dose Of The Sarah Nanotechnology System, For Patients With Stage 4 Metastatic Solid Tumors.The Investigational Device Uses Iron Oxide Nanoparticles Together With Non-Ionizing Alternating Magnetic Field To Generate Heat And Destroy Tumors - Mayo Clinic

    Early Feasibility Study To Evaluate The Safety And Recommended Dose Of The Sarah Nanotechnology System, For Patients With Stage 4 Metastatic Solid Tumors.The ...

  3. Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Equitable AI Addressing Expanding Artificial Intelligence And Machine Learning To Improve Recovery From Acute Illness: A Patient-Focused Collaborative Hospital Repository Uniting Standards - Mayo Clinic

    Equitable AI Addressing Expanding Artificial Intelligence And Machine Learning To Improve Recovery From Acute Illness: A Patient-Focused Collaborative Hospital ...

  5. A Study of Everolimus with or without Bevacizumab for Treating Patients with Advanced Kidney Cancer that Progressed after First-Line Therapy - Mayo Clinic

    Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can interfere ...

  6. A Study for the Use of Hepatitis C Virus Seropositive Donors into Hepatitis C Seronegative Liver Transplant Recipients - Mayo Clinic

    The purpose of this study is to utilize liver allografts from HCV seropositive donors into 10 HCV seronegative recipients. Participation eligibility.

  7. A Study Investigating Integrated Genomics and Patient-derived Cancer Models - Mayo Clinic

    About this study. The aim of this project is to characterize a landscape of DNA alterations and proteomic changes in both biopsies and resected tumors of ...

  8. Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Study to Distinguish Mood Disorders - Mayo Clinic

    The goal of this proposed study is to examine the genetic signature of the validated proteomic signature (model) based on a panel of serum proteomic markers ...

  10. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...